Total Payments
$45,149
2024 Payments
$3,894
Companies
3
Transactions
55
Medicare Patients
3,473
Medicare Billing
$133,497
Payment Breakdown by Category
Consulting$39,174 (86.8%)
Travel$5,036 (11.2%)
Food & Beverage$938.78 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,174 | 13 | 86.8% |
| Travel and Lodging | $5,036 | 18 | 11.2% |
| Food and Beverage | $938.78 | 24 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $35,716 | 50 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $5,539 | 4 | $0 (2022) |
| Roche Diagnostics Corporation | $3,894 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,894 | 1 | Roche Diagnostics Corporation ($3,894) |
| 2022 | $5,539 | 4 | AstraZeneca Pharmaceuticals LP ($5,539) |
| 2021 | $1,300 | 1 | Merck Sharp & Dohme Corporation ($1,300) |
| 2020 | $650.00 | 1 | Merck Sharp & Dohme Corporation ($650.00) |
| 2019 | $4,434 | 7 | Merck Sharp & Dohme Corporation ($4,434) |
| 2018 | $9,718 | 15 | Merck Sharp & Dohme Corporation ($9,718) |
| 2017 | $19,614 | 26 | Merck Sharp & Dohme Corporation ($19,614) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Roche Diagnostics Corporation | — | Consulting Fee | Cash or cash equivalent | $3,894.00 | General |
| Category: None | ||||||
| 12/14/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $3,025.00 | General |
| Category: Oncology | ||||||
| 11/11/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $54.07 | General |
| Category: Oncology | ||||||
| 11/11/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $39.61 | General |
| Category: Oncology | ||||||
| 10/16/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| Category: Oncology | ||||||
| 06/25/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 09/25/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 05/20/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 05/20/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $57.49 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $289.94 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $281.37 | General |
| 11/26/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 11/26/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/09/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $245.37 | General |
| 11/09/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/09/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $45.14 | General |
| 11/09/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/08/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $451.84 | General |
| 08/20/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 04/30/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 04/30/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/19/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $384.64 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 961 | 1,127 | $181,823 | $41,197 |
| 2022 | 10 | 985 | 1,167 | $149,061 | $37,565 |
| 2021 | 10 | 846 | 938 | $117,587 | $30,056 |
| 2020 | 9 | 681 | 772 | $94,242 | $24,679 |
Total Patients
3,473
Total Services
4,004
Medicare Billing
$133,497
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 224 | 248 | $44,528 | $10,927 | 24.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 167 | 208 | $29,537 | $6,478 | 21.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 256 | 271 | $26,296 | $5,948 | 22.6% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 42 | 72 | $18,438 | $4,259 | 23.1% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 38 | 41 | $15,804 | $3,717 | 23.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 32 | 35 | $6,547 | $1,635 | 25.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 13 | 19 | $10,091 | $1,343 | 13.3% |
| 88172 | Evaluation of fine needle aspirate | Office | 2023 | 31 | 33 | $5,474 | $1,305 | 23.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 18 | 46 | $6,150 | $1,110 | 18.1% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2023 | 15 | 15 | $2,889 | $1,089 | 37.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 32 | 35 | $5,317 | $1,038 | 19.5% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 33 | 35 | $2,695 | $633.27 | 23.5% |
| 88141 | Pap test | Facility | 2023 | 26 | 26 | $2,860 | $523.81 | 18.3% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Office | 2023 | 11 | 19 | $1,824 | $474.05 | 26.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 12 | 13 | $2,306 | $461.25 | 20.0% |
| 88104 | Cell examination of body fluid, smears | Facility | 2023 | 11 | 11 | $1,067 | $255.20 | 23.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 291 | 323 | $31,008 | $7,575 | 24.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 151 | 215 | $28,165 | $7,132 | 25.3% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 45 | 96 | $23,424 | $6,077 | 25.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2022 | 213 | 236 | $22,656 | $5,240 | 23.1% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2022 | 72 | 75 | $18,880 | $4,666 | 24.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 58 | 59 | $7,838 | $1,959 | 25.0% |
| 88172 | Evaluation of fine needle aspirate | Office | 2022 | 48 | 51 | $6,517 | $1,605 | 24.6% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 14 | 14 | $1,528 | $1,044 | 68.3% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2022 | 35 | 39 | $3,003 | $767.05 | 25.5% |
About Dr. Maureen Zakowski, MD
Dr. Maureen Zakowski, MD is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619957578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maureen Zakowski, MD has received a total of $45,149 in payments from pharmaceutical and medical device companies, with $3,894 received in 2024. These payments were reported across 55 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($39,174).
As a Medicare-enrolled provider, Zakowski has provided services to 3,473 Medicare beneficiaries, totaling 4,004 services with total Medicare billing of $133,497. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 01/18/2006
- Last Updated 05/23/2016
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1619957578
Products in Payments
- KEYTRUDA (Biological) $7,429
- TAGRISSO (Drug) $3,119
- IMFINZI (Biological) $2,420
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Anatomic Pathology $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Anatomic Pathology $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Anatomic Pathology $74,599
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Anatomic Pathology $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029
Anatomic Pathology $34,029
Laura Tang, Md, Phd, MD, PHD
Anatomic Pathology — Payments: $30,752
Anatomic Pathology $30,752